Mesenchymal Stromal Cell Therapy to Prevent Bronchopulmonary Dysplasia in Extreme Preterm Infants

Clinical trial NCT07058025 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07058025
Sponsor: Ottawa Hospital Research Institute
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Bronchopulmonary Dysplasia (BPD)ELGAN (22-28SA)

Start date: 2025-10-01
Primary completion: 2028-09-30
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.